Company Overview
Company Type: Private Company
Company Status: Operating Subsidiary
Website: www.cytivalifesciences.com
Global Number of Employees (Latest): 3,955
Year Founded: 1968
Total Amount Raised (CAD mm)†: -
Total Rounds of Funding**:-
Latest Post-Money Valuation ($ mm) -
Latest Pre-Money Valuation ($ mm) -
† This number reflects the estimated value of the total new money raised through private placement rounds.
** This value is an estimate of the total number of funding rounds this company has received.


Business Description
Global Life Sciences Solutions USA LLC offers equipment and supplies for therapeutics. It offers products for bioprocess filtration; cell culture and fermentation process; fixed and live cell research; cell therapy technologies; chromatography; laboratory supplies and accessories; whatman filters, membranes, and devices; liquid preparation and management; molecular biology and biochemistry; and protein analysis. The company also provides service plans and training. Global Life Sciences Solutions USA LLC provides services including optirun, biomanufacturing, instruments qualification, and scientific support. It serves applications including bioprocessing; cell and gene therapy; cellular analysis; diagnostics; emerging biotech; enterprise solutions; genomics; lab filtration; and protein research. The company was formerly known as GE Healthcare Bio-Sciences Corp. and changed its name to Global Life Sciences Solutions USA LLC in October 2019. Global Life Sciences Solutions USA LLC was incorporated in 1968 and is based in Marlborough, Massachusetts. Global Life Sciences Solutions USA LLC operates as a subsidiary of Danaher Corporation.


Financial Information (Currency: CAD, in mm)
Total Revenue
 1,158.1
Operating Income
-
Total Assets
-
Gross Profit
-
EBITDA
-
Total Debt
-
Net Income
-
Global Number of Employees (Latest)
 3,955
Net Debt
-
U.S. Number of Employees 2019
 139
U.S. Number of Employees 2018
 152
U.S. Last Year Employee Growth %
 (8.6)
* Hover over data point numbers for date and source.

Key Professionals
No Key Professionals have been profiled.


Primary Industry Classification
Life Sciences Tools and Services


Primary Office Location
100 Results Way | Marlborough, MA | 01752 | United States
Phone: 800 526 3593   

Parent Company
Danaher Corporation (NYSE:DHR)


Company Notes
No Company Notes exist.


Strategy Notes
No Strategy Notes exist.


Last 5 Transactions
Announced Date
Closed Date
Transaction Type
Role
Target
Buyer/Investors
Sellers
Size($mm)
Dec-10-2019
Jul-01-2019
Merger/Acquisition
Seller
Qiagen Healthcare Biotechnologies Limited
Qiagen N.V. (NYSE:QGEN)
Global Life Sciences Solutions USA LLC,GE Healthcare Limited,GE HEALTHCARE UK LIMITED
33.80
Apr-23-2012
Apr-23-2012
Merger/Acquisition
Seller
Integenx Acquisition Corp.
IntegenX Inc.
GE Healthcare Bio-Sciences Corp. (nka:Global Life Sciences Solutions USA LLC)
-
* denotes that the relationship is proprietary


Last 5 Key Developments
Date
Event Type
Headline
Sep-18-2023
Company Conference Presentations
Global Life Sciences Solutions USA LLC Presents at BioProcess International Conference & Exhibition, Sep-18-2023
Feb-27-2023
Company Conference Presentations
Global Life Sciences Solutions USA LLC Presents at Field Service Medical 2023, Feb-27-2023
Dec-10-2019
M&A Transaction Closings
QIAGEN N.V. (NYSE:QGEN) acquired GE Healthcare Biotechnologies Ltd. from GE Healthcare Bio-Sciences Corp., GE Healthcare Limited and GE Healthcare UK Limited for $33.8 million.
Mar-26-2014
Client Announcements
Super Resolution Technologies LLC Enters into Settlement and Patent License Agreement with GE Healthcare Biosciences Corp
Apr-23-2012
M&A Transaction Closings
IntegenX, Inc. acquired SV Corp from GE Healthcare Bio-Sciences Corp.


Last 10 Investment Research Documents
Contributor
Analyst
Date/Time
Company
Headline
Type
Pages
GlobalData

Sep 29, 2023 01:19 AM
Global Life Sciences Solutions USA LLC
Global Life Sciences Solutions USA LLC
Reports
218
GlobalData

Jul 27, 2023 03:03 AM
Global Life Sciences Solutions USA LLC
Global Life Sciences Solutions USA LLC
Reports
15
GlobalData

Jun 28, 2023 02:04 AM
Global Life Sciences Solutions USA LLC
Global Life Sciences Solutions USA LLC
Reports
15
GlobalData

Mar 31, 2023 02:04 AM
Global Life Sciences Solutions USA LLC
Global Life Sciences Solutions USA LLC
Reports
15


S&P Global Ratings Credit Ratings
No S&P Global Ratings Credit Ratings data available. 


News Headlines
No News is currently available for the selected sources.


Company Coverage
This company is not on any Coverage List.


Upcoming Events
Date/Time
Type
Oct-30-2023
Conferences
Oct-31-2023 11:55 AM (KST)
Company Conference Presentations
Nov-08-2023
Conferences
* Future Events are subject to change.

Key Executives and Professionals Details
No Key Executives and Professionals exist.

S&P Credit Ratings and Research provided by 
No content (including ratings, credit-related analyses and data, valuations, model, software or other application or output therefrom) or any part thereof (Content) may be modified, reverse engineered, reproduced or distributed in any form by any means, or stored in a database or retrieval system, without the prior written permission of S&P Global Market Intelligence or its affiliates (collectively, S&P Global). The Content shall not be used for any unlawful or unauthorized purposes. S&P Global and any third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively S&P Global Parties) do not guarantee the accuracy, completeness, timeliness or availability of the Content. S&P Global Parties are not responsible for any errors or omissions (negligent or otherwise), regardless of the cause, for the results obtained from the use of the Content, or for the security or maintenance of any data input by the user. The Content is provided on an "as is" basis. S&P GLOBAL PARTIES DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE, FREEDOM FROM BUGS, SOFTWARE ERRORS OR DEFECTS, THAT THE CONTENT’S FUNCTIONING WILL BE UNINTERRUPTED OR THAT THE CONTENT WILL OPERATE WITH ANY SOFTWARE OR HARDWARE CONFIGURATION. In no event shall S&P Global Parties be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs or losses caused by negligence) in connection with any use of the Content even if advised of the possibility of such damages.

Credit-related and other analyses, including ratings, and statements in the Content are statements of opinion as of the date they are expressed and not statements of fact. S&P Global Market Intelligence’s opinions, analyses and rating acknowledgment decisions (described below) are not recommendations to purchase, hold, or sell any securities or to make any investment decisions, and do not address the suitability of any security. S&P Global Market Intelligence assumes no obligation to update the Content following publication in any form or format. The Content should not be relied on and is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment and other business decisions. S&P Global Market Intelligence does not act as a fiduciary or an investment advisor except where registered as such. While S&P Global Market Intelligence has obtained information from sources it believes to be reliable, S&P Global Market Intelligence does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives.

S&P Global keeps certain activities of its divisions separate from each other in order to preserve the independence and objectivity of their respective activities. As a result, certain divisions of S&P Global may have information that is not available to other S&P Global divisions. S&P Global has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process.

S&P Global Ratings does not contribute to or participate in the creation of credit scores generated by S&P Global Market Intelligence. Lowercase nomenclature is used to differentiate S&P Global Market Intelligence PD credit model scores from the credit ratings issued by S&P Global Ratings.

S&P Global may receive compensation for its ratings and certain analyses, normally from issuers or underwriters of securities or from obligors. S&P Global reserves the right to disseminate its opinions and analyses. S&P Global's public ratings and analyses are made available on its Web sites, www.standardandpoors.com (free of charge), and www.capitaliq.com (subscription), and may be distributed through other means, including via S&P Global publications and third-party redistributors. Additional information about our ratings fees is available at www.standardandpoors.com/usratingsfees.
Regulatory News Service data provided by 
